- Report
- June 2023
- 241 Pages
Global
From €7297EUR$7,500USD£6,251GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1946EUR$2,000USD£1,667GBP
- Clinical Trials
- January 2024
- 90 Pages
Global
From €1459EUR$1,500USD£1,250GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1946EUR$2,000USD£1,667GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1459EUR$1,500USD£1,250GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1459EUR$1,500USD£1,250GBP
- Drug Pipelines
- January 2024
- 96 Pages
Global
From €1459EUR$1,500USD£1,250GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1459EUR$1,500USD£1,250GBP
- Report
- February 2024
- 468 Pages
Global
From €4669EUR$4,799USD£4,000GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1216EUR$1,250USD£1,042GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1946EUR$2,000USD£1,667GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1216EUR$1,250USD£1,042GBP
- Drug Pipelines
- March 2024
- 60 Pages
Global
From €1216EUR$1,250USD£1,042GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1459EUR$1,500USD£1,250GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1946EUR$2,000USD£1,667GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1459EUR$1,500USD£1,250GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1946EUR$2,000USD£1,667GBP
- Report
- August 2019
- 488 Pages
Global
From €3891EUR$3,999USD£3,333GBP
- Report
- February 2022
- 272 Pages
Global
From €5838EUR$6,000USD£5,001GBP
- Report
- May 2020
- 247 Pages
Global
From €8027EUR$8,250USD£6,876GBP
The Oncogene market is a subset of the Genomics market that focuses on the study of cancer-causing genes. Oncogenes are genes that have the potential to cause cancer when they are mutated or expressed at high levels. Oncogenes are studied to understand the molecular basis of cancer and to develop new treatments. Research in this field has led to the development of targeted therapies, such as monoclonal antibodies, small molecule inhibitors, and gene therapies.
The Oncogene market is highly competitive, with many companies developing new technologies and treatments. Companies in the market include Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, and Bio-Rad Laboratories. Show Less Read more